Europe Pharmacogenomics Market to Grow at a CAGR of 10.2% to reach US$ 3,874.31 Million from 2021 to 2028

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Pharmacogenomics Market – By Technology

1.3.2 Europe Pharmacogenomics Market – By Application

1.3.3 Europe Pharmacogenomics Market – By End User

1.3.4 Europe Pharmacogenomics Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Pharmacogenomics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe PEST Analysis

4.3 Experts Opinion

5. Pharmacogenomics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Chronic Diseases

5.1.2 Growing Funding for Pharmacogenomics

5.2 Market Restraints

5.2.1 Lack of Skilled Professionals

5.3 Market Opportunities

5.3.1 Increasing Demand for Third Generation Sequencing

5.4 Future Trends

5.4.1 Increasing Demand for Personalized Medicines

6. Pharmacogenomics Market–Europe Analysis

6.1 Europe Pharmacogenomics Market Revenue Forecast and Analysis

7. Pharmacogenomics Market Revenue and Forecasts To 2028 – Technology

7.1 Overview

7.2 Europe Pharmacogenomics Market Share by Technology - 2021 & 2028 (%)

7.3 Polymerase Chain Reaction

7.3.1 Overview

7.3.2 Polymerase Chain Reaction: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.3.3 Real Time PCR

7.3.3.1 Overview

7.3.3.2 Real Time PCR: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.3.4 Standard PCR

7.3.4.1 Overview

7.3.4.2 Standard PCR: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.3.5 Digital PCR

7.3.5.1 Overview

7.3.5.2 Digital PCR: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.4 Sequencing

7.4.1 Overview

7.4.2 Sequencing: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.5 Microarray

7.5.1 Overview

7.5.2 Microarray: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.6 Gel Electrophoresis

7.6.1 Overview

7.6.2 Gel Electrophoresis: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.7 Mass Spectrometry

7.7.1 Overview

7.7.2 Mass Spectrometry: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.8 Others

7.8.1 Overview

7.8.2 Others: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8. Global Pharmacogenomics Market Revenue and Forecasts To 2028– by Application

8.1 Overview

8.2 Europe Pharmacogenomics Market Share by Application- 2021 & 2028 (%)

8.3 Drug Discovery

8.3.1 Overview

8.3.2 Drug Discovery: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.4 Oncology

8.4.1 Overview

8.4.2 Oncology: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.5 Neurology & Psychiatry

8.5.1 Overview

8.5.2 Neurology & Psychiatry: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.6 Pain Management

8.6.1 Overview

8.6.2 Pain Management: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.7 Cardiovascular Disease

8.7.1 Overview

8.7.2 Cardiovascular Disease: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

9. Pharmacogenomics Market Revenue and Forecasts To 2028 – End User

9.1 Overview

9.2 Europe Pharmacogenomics Market Share by End User - 2021 & 2028 (%)

9.3 Hospitals and Clinics

9.3.1 Overview

9.3.2 Hospitals and Clinics: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

9.4 Biopharmaceutical Companies

9.4.1 Overview

9.4.2 Biopharmaceuticals Companies: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

9.5 CROs and CDMOs

9.5.1 Overview

9.5.2 CROs and CDMOs: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

10. Pharmacogenomics Market Revenue and Forecasts to 2028 –Country Analysis

10.1 Europe: Pharmacogenomics Market

10.1.1 Overview

10.1.2 Europe: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3 Europe: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.3.1 Europe: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.4 Europe: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.5 Europe: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.1.6 Europe: Pharmacogenomics Market, by Country, 2021 & 2028 (%)

10.1.6.1 Germany: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1 Overview

10.1.6.1.2 Germany: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.3 Germany: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.3.1 Germany: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.6.1.4 Germany: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.5 Germany: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2 France: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1 Overview

10.1.6.2.2 France: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.3 France: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.3.1 France: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.6.2.4 France: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.5 France: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3 UK: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1 Overview

10.1.6.3.2 UK: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.3 UK: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.3.1 UK: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.6.3.4 UK: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.5 UK: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.1.6.4 Italy: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.1 Overview

10.1.6.4.2 Italy: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.3 Italy: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.3.1 Italy: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.6.4.4 Italy: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.5 Italy: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.1.6.5 Spain: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.1 Overview

10.1.6.5.2 Spain: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.3 Spain: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.3.1 Spain: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.6.5.4 Spain: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.5 Spain: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.1.6.6 Rest of Europe: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.6.1 Overview

10.1.6.6.2 Rest of Europe: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.6.3 Rest of Europe: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.6.3.1 Rest of Europe: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.6.6.4 Rest of Europe: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.6.5 Rest of Europe: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

11. Impact of COVID-19 Pandemic on Europe Pharmacogenomics Market

11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 F. HOFFMANN-LA ROCHE LTD.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Oxford Nanopore Technologies

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 THERMO FISHER SCIENTIFIC INC.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Illumina, Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 QIAGEN

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Agilent Technologies, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Myriad Genetics, Inc.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 2. Europe: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 3. Europe: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 4. Europe: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 5. Germany: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 6. Germany: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 7. Germany: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 8. Germany: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 9. France: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 10. France: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 11. France: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 12. France: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 13. UK: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 14. UK: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 15. UK: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 16. UK: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 17. Italy: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 18. Italy: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 19. Italy: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 20. Italy: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 21. Spain: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 22. Spain: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 23. Spain: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 24. Spain: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 25. Rest of Europe: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 26. Rest of Europe: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 27. Rest of Europe: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 28. Rest of Europe: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 29. Organic Developments Done By Companies

Table 30. Inorganic Developments Done By Companies

Table 31. Glossary of Terms

LIST OF FIGURES

Figure 1. Pharmacogenomics Market Segmentation

Figure 2. Pharmacogenomics Market, By Country

Figure 3. Europe Pharmacogenomics Market Overview

Figure 4. PCR Segment Held Largest Share of Technology Segment in Pharmacogenomics Market

Figure 5. Pharmacogenomics Market- Leading Country Markets (US$ Million)

Figure 6. Europe: PEST Analysis

Figure 7. Experts Opinion

Figure 8. Europe Pharmacogenomics Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 9. Europe Pharmacogenomics Market Share by Segment - 2021 & 2028 (%)

Figure 10. Polymerase Chain Reaction: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 11. Real Time PCR: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 12. Standard PCR: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 13. Digital PCR: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 14. Sequencing: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 15. Microarray: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 16. Gel Electrophoresis: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17. Mass Spectrometry: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 18. Others: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19. Europe Pharmacogenomics Market Share by Application- 2021 & 2028 (%)

Figure 20. Drug Discovery: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21. Oncology: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22. Neurology & Psychiatry: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23. Pain Management: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24. Cardiovascular Disease: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25. Others: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26. Europe Pharmacogenomics Market Share by End User - 2021 & 2028 (%)

Figure 27. Hospital and Clinics: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 28. Biopharmaceutical Companies: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 29. CROs and CDMOs: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30. Others: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31. Europe: Pharmacogenomics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 32. Europe: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

Figure 33. Europe: Pharmacogenomics Market, by Country, 2021 & 2028 (%)

Figure 34. Germany: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. France: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. UK: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. Italy: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. Spain: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39. Rest of Europe: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40. Impact of COVID-19 Pandemic on Sequencing Reagents Market in European Countries